2872 Dhuda et al.
Asian J. Chem.
viral activity of 9-[(2-hydroxyethoxy)methyl]guanine, the
standard drug for the treatment of herpes viral infections [2].
On the basis of above modifications, researchers turn their
attention to insert saturated heterocycles to the nucleoside to
generate active lead molecules. It has been also noted that the
morpholine/aromatic amines analogous to the nucleosides build
up their supreme space in the current medicinal chemistry [16].
In continuation of our interest on the modification of nucleo-
sides [17] and obtain these diverse scaffolds in higher yields
with shorter reaction times and under milder reaction conditions,
we turned our attention on insertion of acyclic part (morpholine
and alkyl group) in to the purine motif. In this article, we report
the modified purine nucleosides of 2-chloro-9-alkylated-6-
morpholino-9H-purine via highly regioselective C6 acylation
of purines with morpholine catalyzed by Hunig’s base (DIPEA-
N,N-diisopropylethylamine).Alkylation of morpholine-purine
was oriented to N9 using DMF/K2CO3 with 89 % regioselectivity
[18].
of the reaction, it was poured into crushed ice water, dried over
vaccum buchner funnel and purified by column chromatography
using silica 60-120 mesh size as stationary phase [mobile
phase: hexane (60 %):ethyl acetate (40 %)] (Scheme-I). The
isolated purine derivatives were characterized and identified
by various spectroscopic techniques like MS, IR, 1H and 13C NMR.
9-Butyl-2-chloro-6-morpholino-9H-purine (4a): Dark
yellow, yield: 92 %; m.p.: 152 ºC; IR (KBr, cm-1, νmax): 3024.84
(arom. ring C-H str.), 2966.76 (aliph. C-H str. asym.), 2935.25
(aliph. C-H str. sym.), 1584.21, 1514.38, 1487.24 (arom. ring
skeleton), 1258.11 (C-N str.), 1163.33 (C-O str.); 1H NMR (400
MHz, DMSO-d6) δ ppm: 8.23 (s, 1H, CH of imidazole ring),
4.52-4.33 (broad-m, 4H, morpholine -CH2), 4.13-3.95 (m, 2H,
morpholine -CH2), 3.73-3.51 (m, 2H, morpholine -CH2), 1.79-
1.71 (m, 2H, -CH2 of alkyl chain), 1.29-1.18 (m, 2H, -CH2 of
alkyl chain), 1.19-1.17 (t, 3H, -CH3 of alkyl chain), 0.91-0.85
(m, 2H, N-CH2 of alkyl chain); 13C NMR (101 MHz, DMSO-d6)
δ ppm: 153.32, 152.40, 151.73, 140.69, 117.98, 66.01, 31.17,
22.07, 19.15; MS (m/z): 295.76 (M+); Anal. calcd. (found) %
for C13H18N5OCl: C, 52.79 (52.80); H, 6.13 (6.15); N, 23.68
(23.67); O, 5.41 (5.40); Cl, 11.99 (11.98).
EXPERIMENTAL
All the chemicals and reagents were received from Sigma-
Aldrich and Merck. Silica gel plate G60 F254 (Merck) was used
in thin layer chromatography to monitor the completion of
the reaction. Visualization was made under UV light (254 and
365 nm). Infrared spectra of the compounds were recorded
2-Chloro-6-morpholino-9-(prop-2-ynyl)-9H-purine (4b):
Bright yellow, yield: 96 %; m.p.: 140 ºC; IR (KBr, cm-1, νmax):
3101.51 (arom. ring C-H str.), 2979.73 (aliph. C-H str. asym.),
2967.96 (aliph. C-H str. sym.), 2128.56 (C≡C str.), 1584.09,
1514.40, 1460.71 (arom. ring skeleton), 1261.00 (C-N str.),
1
on IR Affinity-1S spectrophotometer (Shimadzu). H (400
MHz) and 13C (101.1 MHz) NMR spectra were recorded on a
Bruker AVANCE II spectrometer in DMSO-d6. Mass spectro-
meter GCMS-QP 2010 (Shimadzu) was used to resolute the
mass spectra of compounds and rotary evaporator was used
for drying the compounds. Melting points were measured by
open capillary method and are uncorrected.
1
1140.71 (C-O str.); H NMR (400 MHz, DMSO-d6) δ ppm:
8.27 (s, 1H, CH of imidazole ring), 5.04-5.03 (m, 2H, propargyl
-CH2), 4.43 (broad, 4H, morpholine-CH2), 3.91-3.84 (m, 4H,
morpholine -CH2), 3.53 (s, 1H, ≡CH of propargyl); 13C NMR
(101 MHz, DMSO-d6) δ ppm: 152.72, 151.26, 139.94, 118.22,
77.77, 76.28, 65.98, 32.63; MS (m/z): 277.70 (M+);Anal. calcd.
(found) % for C12H12N5OCl: C, 51.90 (51.93); H, 4.36 (4.38);
Cl, 12.77(12.75); N, 25.22 (25.20); O, 5.76 (5.75).
Synthesis of 2-chloro-6-morpholino-9H-purine (3)
(step I): To a n-butanol containing round bottom flask, 2,6-
dichloropurine (1) (50 mmol), N,N-diisopropylethylamine
(DIPEA) (10 mmol) and morpholine (2) (50 mmol) were added
and was refluxed at 80 ºC for 2 h to generate a reactive inter-
mediate (3). Thin layer chromatography [hexane(7):ethyl acetate
(3)] was utilized to identify the complete formation of product.
After 12 h stirring at room temperature, it was poured into
ice-cold water and stirred for 1 h to isolate free material in
powder form. The separated product was filtered and washed
with cold water. The isolated product was dried for next 12 h
at room temperature.
For the purification purpose, hexane stripping was perfor-
med using roteva evaporator at 60 ºC and 500 mm pressure
through 100 rpm speed. The step-I crude product was charact-
erized by 1H NMR and IR techniques to carry out further reactions.
Synthesis of 2-chloro-9-alkylated-6-morpholino-9H-
purine (4a-f) (step II): Into a vaccum dried round bottom flask,
product (3) (3 mmol), powdered form of potassium carbonate
(K2CO3) (10 mmol) and DMF (1 mL) were heated at 80 ºC for
2 h to generate nucleophile at N9 position of purine. After 2 h
heating, various alkyl halides (5.5 mmol) were charged at heating
condition using micropipette to the reaction mixture and continue
to heating for 3 h for the completion of reaction. It was monitored
by TLC using two different mobile phase systems [hexane (7):
ethyl acetate (3) & ethyl acetate (100 %)]. After completion
2-Chloro-9-isopropyl-6-morpholino-9H-purine (4c):
Yellow, yield: 91 %; m.p.: 152 ºC; IR (KBr, cm-1, νmax): 3031.26
(arom. ring C-H str.), 2965.22 (aliph. C-H str. asym.), 2939.20
(aliph. C-H str. sym.), 1589.48, 1521.59, 1496.21 (arom. ring
1
skeleton), 1259.99 (C-N str.), 1156.56 (C-O str.); H NMR
(400 MHz, DMSO-d6) δ ppm: 8.25 (s, 1H, CH of imidazole
ring), 5.01-4.99 (m, 2H, propargyl -CH2), 4.49 (broad, 4H,
morpholine -CH2), 3.99-3.91 (m, 4H, morpholine -CH2), 4.38
(m, 1H, -CH of isopropyl), 1.52-1.51 (d, 6H, -CH3 of iso-propyl);
13C NMR (101 MHz, DMSO-d6) δ ppm: 159.63, 155.11, 147.70,
142.35, 135.34, 65.59, 48.20, 45.92, 45.92, 18.84, 18.84; MS
(m/z): 281.74 (M+);Anal. calcd. (found) % for C12H16N5OCl: C,
51.16 (51.15); H, 5.72 (5.72); N, 24.86 (24.84); O, 5.68 (5.70);
Cl, 12.58 (12.59).
2-Chloro-6-morpholino-9-propyl-9H-purine (4d): Off-
whitish yellow, yield: 92 %; m.p.: 136 ºC; IR (KBr, cm-1, νmax):
3103.20 (arom. ring C-H str.), 2989.01 (aliph. C-H str. asym.),
2941.20 (aliph. C-H str. sym.), 1590.10, 1555.21, 1489.04(arom.
ring skeleton), 1269.23 (C-N str.), 1151.22 (C-O str.); 1H NMR
(400 MHz, DMSO-d6) δ ppm: 8.29 (s, 1H, CH of imidazole
ring), 4.45-4.39 (broad-m, 4H, morpholine -CH2), 4.20-4.12
(m, 2H, morpholine-CH2), 3.88-3.78 (m, 2H, -CH2 alkyl chain),
3.70-3.63 (m, 2H, morpholine-CH2), 1.83-1.79 (m, 2H, -CH2
alkyl chain), 1.04-1.01 (t, 3H, -CH3 alkyl chain); 13C NMR (101